Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Josep M Grinyo"'
Autor:
Fernanda Ortiz, Rosana Gelpi, Ilkka Helanterä, Edoardo Melilli, Eero Honkanen, Oriol Bestard, Josep M Grinyo, Josep M Cruzado
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0159717 (2016)
The pros and cons for implementing protocol biopsies (PB) after kidney transplantation are still a matter of debate. We aimed to address the frequency of pathological findings in PB, to analyze their impact on long-term graft survival (GS) and to ana
Externí odkaz:
https://doaj.org/article/f5e5d1626dbc426394ab383e16b789d1
Autor:
Obbo W. Bredewold, Joe Chan, My Svensson, Annette Bruchfeld, Johan W. de Fijter, Hans Furuland, Josep M. Grinyo, Anders Hartmann, Hallvard Holdaas, Olof Hellberg, Alan Jardine, Lars Mjörnstedt, Karin Skov, Knut T. Smerud, Inga Soveri, Søren S. Sørensen, Anton-Jan van Zonneveld, Bengt Fellström
Publikováno v:
Bredewold, O W, Chan, J, Svensson, M, Bruchfeld, A, de Fijter, J W, Furuland, H, Grinyo, J M, Hartmann, A, Holdaas, H, Hellberg, O, Jardine, A, Mjörnstedt, L, Skov, K, Smerud, K T, Soveri, I, Sørensen, S S, Zonneveld, A-J V & Fellström, B 2023, ' Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients : A Randomized Clinical Trial ', Kidney Medicine, vol. 5, no. 1, 100574 . https://doi.org/10.1016/j.xkme.2022.100574
Bredewold, O W, Chan, J, Svensson, M, Bruchfeld, A, Fijter, J W D, Furuland, H, Grinyo, J M, Hartmann, A, Holdaas, H, Hellberg, O, Jardine, A, Mjörnstedt, L, Skov, K, Smerud, K T, Soveri, I, Sörensen, S S, van Zonneveld, A J & Fellström, B 2023, ' Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial ', Kidney Medicine, vol. 5, no. 1, 100574 . https://doi.org/10.1016/j.xkme.2022.100574
Bredewold, O W, Chan, J, Svensson, M, Bruchfeld, A, de Fijter, J W, Furuland, H, Grinyo, J M, Hartmann, A, Holdaas, H, Hellberg, O, Jardine, A, Mjörnstedt, L, Skov, K, Smerud, K T, Soveri, I, Sørensen, S S, Zonneveld, A J V & Fellström, B 2023, ' Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients : A Randomized Clinical Trial ', Kidney Medicine, vol. 5, no. 1, 100574 . https://doi.org/10.1016/j.xkme.2022.100574
Bredewold, O W, Chan, J, Svensson, M, Bruchfeld, A, Fijter, J W D, Furuland, H, Grinyo, J M, Hartmann, A, Holdaas, H, Hellberg, O, Jardine, A, Mjörnstedt, L, Skov, K, Smerud, K T, Soveri, I, Sörensen, S S, van Zonneveld, A J & Fellström, B 2023, ' Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial ', Kidney Medicine, vol. 5, no. 1, 100574 . https://doi.org/10.1016/j.xkme.2022.100574
Bredewold, O W, Chan, J, Svensson, M, Bruchfeld, A, de Fijter, J W, Furuland, H, Grinyo, J M, Hartmann, A, Holdaas, H, Hellberg, O, Jardine, A, Mjörnstedt, L, Skov, K, Smerud, K T, Soveri, I, Sørensen, S S, Zonneveld, A J V & Fellström, B 2023, ' Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients : A Randomized Clinical Trial ', Kidney Medicine, vol. 5, no. 1, 100574 . https://doi.org/10.1016/j.xkme.2022.100574
RATIONALE & OBJECTIVE: In kidney transplant recipients (KTRs), a belatacept-based immunosuppressive regimen is associated with beneficial effects on cardiovascular (CV) risk factors compared with calcineurin inhibitor (CNI)-based regimens. Our object
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b69b94a611d7a310d374c44136f21cf6
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-498007
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-498007
Autor:
Obbo W. Bredewold, Joe Chan, My Svensson, Annette Bruchfeld, Johan W. Fijter, Hans Furuland, Josep M. Grinyo, Anders Hartmann, Hallvard Holdaas, Olof Hellberg, Alan Jardine, Lars Mjörnstedt, Karin Skov, Knut T. Smerud, Inga Soveri, Sören S. Sörensen, Anton-Jan Zonneveld, Bengt Fellstrom
In renal transplant recipients (RTRs), a belatacept-based immunosuppressive regimen is associated with beneficial effects on cardiovascular (CV) risk factors compared with calcineurin inhibitor (CNI)-based regimens. The aim of this randomized, multi-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5eac222c1e58682c102b6e3108952dd8
https://doi.org/10.21203/rs.3.rs-1283060/v1
https://doi.org/10.21203/rs.3.rs-1283060/v1
Autor:
Josep M, Grinyo
Publikováno v:
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 20(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a22a8a19a8cbc0743f922349c61729b1
https://pubmed.ncbi.nlm.nih.gov/19237802
https://pubmed.ncbi.nlm.nih.gov/19237802
Publikováno v:
Contributions to nephrology. 159
Thanks to the progressive understanding of the cellular and molecular basis of renal function and disease, during the next several decades new therapeutic approaches to a wide range of kidney disorders, including acute renal failure (ARF), will be de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::efd8fb2e55a4a77462c56a907df70a2d
https://pubmed.ncbi.nlm.nih.gov/18391587
https://pubmed.ncbi.nlm.nih.gov/18391587
Publikováno v:
Transplantation. 74(11)
Sirolimus (Rapamune; SRL) in combination with cyclosporine (CsA) reduces the incidence of acute rejection episodes in renal allograft recipients. This study evaluated whether renal function could be improved by elimination of CsA from an SRL-based re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dcbe1b0f589fd349d9e50129b77697ad
https://pubmed.ncbi.nlm.nih.gov/12490789
https://pubmed.ncbi.nlm.nih.gov/12490789
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Francesc Moreso, Josep M. Grinyo
Publikováno v:
Nephrology Dialysis Transplantation; Mar2007, Vol. 22 Issue 3, p699-702, 4p
Autor:
Alonso Narváez, Roser Guiteras, Anna Sola, Anna Manonelles, Juan Morote, Juan Torras, Josep M Grinyó, Josep M Cruzado
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0215232 (2019)
BackgroundThe costimulatory CD40-CD40L pathway plays a role in kidney inflammation. We have previously reported that renal CD40 upregulation precedes cellular interstitial infiltrate and fibrosis in the unilateral ureteral obstruction (UUO) model. He
Externí odkaz:
https://doaj.org/article/f3b33dfb424e4386a4b43c0d4b2c3332
Autor:
Ines Rama, Ines Llaudó, Pere Fontova, Gema Cerezo, Carlos Soto, Casimiro Javierre, Miguel Hueso, Nuria Montero, Alberto Martínez-Castelao, Juan Torras, Josep M Grinyó, Josep M Cruzado, Nuria Lloberas
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164969 (2016)
Patients undergoing conventional hemodialysis (C-HD) present a greater immuno-inflammatory state probably related to uremia, sympathetic nervous system (SNS) activation and /or membrane bioincompatibility, which could improve with a technique-switchi
Externí odkaz:
https://doaj.org/article/9e69733e077c47f0b182c2c9a1d8f6e3